Operating Lease, Liability of Enlivex Therapeutics Ltd. from 31 Dec 2022 to 30 Jun 2025

Taxonomy & unit: us-gaap: USD
Description: Present value of lessee's discounted obligation for lease payments from operating lease.
Summary: Enlivex Therapeutics Ltd. quarterly Operating Lease, Liability in USD history and change rate from 31 Dec 2022 to 30 Jun 2025.
Enlivex Therapeutics Ltd. Operating Lease, Liability for the quarter ending 30 Jun 2025 was $480,000, a 43% decline year-over-year.
Source SEC data: View on sec.gov

Operating Lease, Liability, Quarterly (USD)

Operating Lease, Liability, YoY Quarterly Change (%)

Enlivex Therapeutics Ltd. Quarterly Operating Lease, Liability (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q2 2025	$480,000	-$355,000	-43%	30 Jun 2025	6-K	29 Aug 2025	2025	Q2
Q4 2024	$534,000	-$498,000	-48%	31 Dec 2024	6-K	29 Aug 2025	2025	Q2
Q2 2024	$835,000	-$3,534,000	-81%	30 Jun 2024	6-K	30 Aug 2024	2024	Q2
Q4 2023	$1,032,000	-$3,815,000	-79%	31 Dec 2023	20-F	30 Apr 2025	2024	FY
Q2 2023	$4,369,000			30 Jun 2023	6-K	01 Sep 2023	2023	Q2
Q4 2022	$4,847,000			31 Dec 2022	20-F	30 Apr 2024	2023	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.